Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice
P. Chuntova, Y. Hou, R. Naka, Y. Goretsky, T. Nejo, G. Kohanbash, T. Chen, A. L. Mende, M. Montoya, A. Yamamichi, K. M. Downey, D. Diebold, J. Skinner, H.-E. Liang, B. Schwer, H. Okada
This paper develops a novel transgenic mouse model expressing EGFRvIII-CAR on T-cells to study CAR T-cell therapy in syngeneic glioblastoma models.
bioRxiv · Jan 31, 2021Immunology